Curriculum Vitae

DR. SIM MAW SHIN

Senior Lecturer
  • Department of Pharmaceutical Life Sciences
    Faculty of Pharmacy
  • +603-79676680

BIOGRAPHY

Dr. Gareth Sim Maw Shin is a talented and dedicated senior lecturer at the University of Malaya, Malaysia. He is currently working in the Department of Pharmaceutical Life Sciences, within the esteemed Faculty of Pharmacy. With a PhD in Medical Science from the University of Malaya, Dr. Gareth joined the faculty as a senior lecturer in 2017. Prior to his PhD, he spent three years as a SLAI fellow under the Academic Training Scheme from the Ministry of Education Malaysia.

Dr. Gareth's expertise in teaching is reflected in his role as coordinator of four Pharmacy and Biomedical modules. He is also highly regarded in the research community, with a focus on Behavioural Science, Genetic Epidemiology, and Psycho- and Neuro-pharmacogenomics in drug abuse and dependence. He is currently leading a cutting-edge project on 'Psychopharmacogenomics of Amphetamine-type Stimulants (ATS) Abuse and Dependence in the Malaysian Population'.

With a strong collaboration network that includes esteemed institutions such as Monash University, Mahsa University, and more, Dr. Gareth has published several high-impact articles in prestigious journals such as Brain Research, Biochimica et Biophysica Acta (BBA) - General Subjects, and the Pharmacogenomics journal. His contributions to the field have made a significant impact and demonstrate his commitment to advancing the field of pharmacogenomics.

AREAS OF EXPERTISE

  • MEDICAL PHARMACOLOGY
    esophageal cancer, chemoresistance, chemosensitivity
  • MEDICAL PHARMACOLOGY
    Dengue fever infection, genetics variation, prevalent
  • OTHER NEUROSCIENCES
    genetic polymorphism, animal behavior, addiction, methamphetamine, proteomic, microRNA
  • PHARMACOGENOMICS
    Pharmacogenomics, addiction, methamphetamine abuse

ACADEMIC QUALIFICATION

  • PhD, (Pharmacogenomics)
    Universiti Malaya (UM)
  • MMedSc, (Medical Science)
    Universiti Malaya (UM)
  • BSc(Gen&MolBio), (Genetik dan Biologi Molekul)
    Universiti Malaya (UM)

ADMINISTRATIVE DUTIES

  • Faculty Quality Assurance Manager
    01 Jan 2024 - 31 Dec 2026 (Faculty)
  • Programme Quality Assurance Expert
    01 Jan 2024 - 31 Dec 2025 (University Malaya)
  • Ahli Jawatankuasa Pelan Strategik Fakulti Farmasi
    01 Jan 2021 - 31 Dec 2025 (Faculty)
  • Penolong Pengurus Kualiti Fakulti
    18 Sep 2023 - 31 Dec 2025 (Faculty)
  • PENYELARAS DAN WAKIL PERANTARA UMEXPERT DI PERINGKAT PTj
    28 Aug 2023 - 27 Aug 2024 (University Malaya)
  • Module Coordinator for SHE programme GDO0013
    02 Oct 2023 - 29 Feb 2024 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Acting Project Manager Faculty of Pharmacy
    09 Aug 2023 - 06 Oct 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Departmental Examination Vetting Coordinator
    27 Sep 2021 - 26 Sep 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Faculty E-Learning Coordinator
    16 Sep 2021 - 15 Sep 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Module Coordinator for OIA3012, Semester 2, Session 2022/2023
    01 Feb 2023 - 31 Aug 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Module Coordinator for OIA2015, Semester 2, session 2022/2023
    01 Feb 2023 - 31 Aug 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Pelantikan sebagai Pengerusi Mesyuarat Jawatankuasa Penilaian Spesifikasi Perolehan Bekalan
    17 Aug 2023 - 17 Aug 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • AHLI JAWATANKUASA KESELAMATAN DAN KESIHATAN PEKERJAAN KECIL
    20 May 2021 - 19 May 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Pelantikan sebagai Pengerusi Proposal defence untuk semester 1, Sesi 2022/2023
    07 Feb 2023 - 07 Feb 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • AHLI JAWATANKUASA KURIKULUM PERINGKAT FAKULTI (JKKF) BAGI FAKULTI FARMASI
    25 Jan 2021 - 24 Jan 2023 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Module Coordinator
    01 Oct 2018 - 31 Dec 2022 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Assistant Quality Manager
    16 Sep 2019 - 30 Nov 2022 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • FACULTY OF PHARMACY HELPDESK ADMINISTRATOR
    01 Dec 2019 - 30 Nov 2022 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Coordinator of Faculty ICT Unit
    01 Jan 2019 - 30 Nov 2022 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Coordinator
    26 Mar 2022 - 27 Mar 2022 (University Malaya)
  • Coordinator of Research Grant Management Unit, Faculty of Pharmacy
    16 Sep 2019 - 31 Dec 2021 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Member of technical evaluation committee
    21 Nov 2019 - 31 Dec 2020 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Member of technical & price evaluation committee, Faculty of Pharmacy
    11 Nov 2019 - 31 Dec 2020 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Acting Quality Manager Faculty
    14 Jan 2020 - 28 Feb 2020 (Department of Pharmaceutical Life Sciences, Faculty of Pharmacy)
  • Assistant Secretary for departmental meeting
    20 Jul 2018 - 31 Dec 2019 (Department of Pharmacy, Faculty of Medicine)

MEMBERSHIPS

  • CORE MEMBER OF UNIVERSITY OF MALAYA CENTRE FOR ADDICTION SCIENCES (UMCAS), COMMITTEE MEMBER
    2021 to 2022 (University)
  • MALAYSIAN SOCIETY FOR MOLECULAR BIOLOGY AND BIOTECHNOLOGY , MEMBER
    2021 to 2021 (National)
  • MALAYSIAN SOCIETY FOR MOLECULAR BIOLOGY AND BIOTECHNOLOGY , ORDINARY MEMBER
    2020 to 2020 (National)
  • MALAYSIAN SOCIETY FOR MOLECULAR BIOLOGY AND BIOTECHNOLOGY, ORIDINARY MEMBER
    2019 to 2019 (National)

AWARD AND STEWARDSHIP

  • Best Poster Presentation
    Ic-PHIR 2023, 2023 (International)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2022 (University)
  • International Learning Improvement & Teaching Enhancement Conference (LITEC) 2021
    Academic Enhancement and Leadership Development Centre (ADeC), University Malaya, 2021 (University)
  • PEMENANG GERAN INSENTIF PENYELIDIKAN TAJAAN YAYASAN PENYELIDIKAN OTAK, MINDA DAN NEUROSAINS MALAYSIA (YPOMNM)
    YAYASAN PENYELIDIKAN OTAK, MINDA DAN NEUROSAINS MALAYSIA (YPOMNM), 2020 (National)
  • Best Poster Award - Second prize, 2015 Golden Helix Symposia, 11-13 March 2015, Kuala Lumpur
    2015 Golden Helix Symposia, 2015 (International)

PUBLICATIONS

Article in Journal
  1. Abraham Degaga, Sisay Sirgu, Hasniza Zaman Huri, Maw Shin Sim, Tedla Kebede, Birhanemeskel Tegene, Navin Kumar Loganadan, Ephrem Engidawork & Workineh Shibeshi (2023) Association of Met420del Variant of Metformin Transporter Gene SLC22A1 with Metformin Treatment Response in Ethiopian Patients with Type 2 Diabetes, Diabetes, Metabolic Syndrome and Obesity, 16:, 2523-2535, DOI: 10.2147/DMSO.S426632
  2. E.N.K. Sharafaldin, H.Z. Huri, M.S. Sim, et al., Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target, Autoimmunity Reviews (2023), https://doi.org/10.1016/j.autrev.2023.103406
  3. Goh, K.W., Stephen, A., Wu, Y.S., Sim, M.S., Batumalaie, K., Gopinath, S.C.B., Guad, R.M., Kumar, A., Sekar, M., Subramaniyan, V., Fuloria, N.K., Fuloria, S., Velaga, A., Sarker, M.M.R. (2023). Molecular Targets of Aptamers in Gastrointestinal Cancers: Cancer Detection, Therapeutic Applications, and Associated Mechanisms. Journal of Cancer, 14(13), 2491-2516. https://doi.org/10.7150/jca.85260.
  4. Hasif Adli Zakariah, Rahman, A., Yuan Seng Wu, Wahab, S., Rusdi Abdul Rashid, & Maw Shin Sim. (2023). Association Analysis of a GSTP1 Functional Polymorphism with Methamphetamine Dependence and Associated Symptoms in a Multiethnic Malaysian Population. Sains Malaysiana, 52(11), 3211–3222. https://doi.org/10.17576/jsm-2023-5211-14
  5. Rahim, N.S., Wu, Y.S., Sim, M.S. et al. (2023) Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance. Pharmaceuticals. 16(1), 110; https://doi.org/10.3390/ph16010110
  6. Ruzmayuddin Mamat, Rusdi Abd Rashid, Maw Shin Sim, Baharuddin Ibrahim, Suzaily Wahab & Azmir Ahmad (2023): Psychosocial Risk Factors Associated with Lifetime Amphetamine-Type Stimulants (ATS) Dependence in Drug Detention Centres: Perspectives from the Multiethnicity Study, Journal of Psychoactive Drugs, DOI: 10.1080/02791072.2023.2190331
  7. Ruzmayuddin Mamat, Rusdi Abd Rashid, Sim Maw Shin, Baharuddin Ibrahim, Suzaily Wahab & Azmir Ahmad (2023): Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia, Journal of Addictive Diseases, DOI: 10.1080/10550887.2023.2240932
  8. Yahya, D.N.; Guad, R.M.; Wu, Y.S.; Gan, S.H.; Gopinath, S.C.B.; Zakariah, H.A.; Rashid, R.A.; Sim, M.S. (2023) SLC1A2 Gene Polymorphism Influences Methamphetamine-Induced Psychosis. J. Pers. Med., 13, 270. https://doi.org/10.3390/jpm13020270
  9. Bernadette Xin Jie Tune, Maw Shin Sim, Chit Laa Poh, Rhanye Mac Guad, Choy Ker Woon, Iswar Hazarika, Anju Das, Subash C. B. Gopinath, Mariappan Rajan, Mahendran Sekar, Vetriselvan Subramaniyan, Neeraj Kumar Fuloria, Shivkanya Fuloria, Kalaivani Batumalaie and Yuan Seng Wu (2022). Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors. Journal of Oncology 2022(2):1-25. DOI:10.1155/2022/3249766.
  10. Ummi Zulaiqha Hamid, Maw Shin Sim, Rhanye Mac Guad, Vetriselvan Subramaniyan, Mahendran Sekar, Neeraj Kumar Fuloria, Shivkanya Fuloria, Ker Woon Choy, Ismail Muhamad Fareez, Srinivasa Reddy Bonam, Yuan Seng Wu (2022) Molecular Regulatory Roles of Long Non-coding RNA HOTTIP: An Overview in Gastrointestinal Cancer. Curr Mol Med. 22(6):478-490 DOI: 10.2174/1566524021666210806162848
  11. Abdul Wahab NW, Guad RM, Subramaniyan V, Fareez IM, Choy KW, Bonam SR, Selvaraju C, Sim MS, Gopinath SCB, Wu YS. (2021) Human Exfoliated Deciduous Teeth Stem Cells: Features and Therapeutic Effects on Neurogenerative and Hepatobiliary-Pancreatic Diseases. Curr Stem Cell Res Ther, 16(5), 563-576. (IF 3.828) .
  12. Guad RM, Carandang RR, Solidum JN, W. Taylor-Robinson A, Wu YS, Aung YN, et al. (2021) Different domains of dengue research in the Philippines: A systematic review and meta-analysis of questionnaire-based studies. PLoS ONE 16(12): e0261412. https://doi.org/10.1371/journal. pone.0261412
  13. Guad, M.R., Wu, Y.S., Aung, Y.N., Sekaran, S.D., Bruno Wilke, A.B., Low, W.Y., Sim, M.S., Carandang, R.R., Jeffrey, M.S., Taherdoost, H., Sunggip, C., Liew, C.S.L., Murugaiah, C., Subramaniyan, V., Azizan, N. (2021). Different domains of dengue research in Malaysia: A systematic review and meta-analysis of questionnaire-based studies. International Journal of Environmental Research and Public Health. 18(9), 4474. DOi: 10.3390/ijerph18094474 (IF: 3.39)
  14. Ramli, S., Sim, M.S., Guad, R.M., Gopinath, S.C.B., Subramaniyan, V., Fuloria, S., Fuloria, N.K., Choy, K.W., Rana, S. and Wu, Y.S. (2021). Long Noncoding RNA UCA1 in Gastrointestinal Cancers: Molecular Regulatory Roles and Patterns, Mechanisms, and Interactions. J Oncol, 2021, 5519720. doi:10.1155/2021/5519720
  15. Rhanye Mac Guad, Ernest Mangantig, Wah Yun Low, Andrew W Taylor-Robinson, Meram Azzani, Shamala Devi Sekaran, Maw Shin Sim, Nornazirah Azizan (2021). Development and validation of a structured survey questionnaire on knowledge, attitude, preventive practice, and treatment-seeking behaviour regarding dengue among the resident population of Sabah, Malaysia: an exploratory factor analysis. BMC Infect Dis, 21(1), 893. doi:10.1186/s12879-021-06606-6
  16. Ramakrishnan, P., Loh, W. M., Gopinath, S. C.B., Bonam, S. R., Fareez, I. M., Guad, R. M., Sim, M. S., Wu, Y. S. (2020) Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer. Acta Pharmaceutica Sinica B. 10(3): 399-413. (Impact factor: 11.413)
  17. Sim MS, Soga T, Pandy V, Wu YS, Parhar IS, Mohamed Z. (2017) MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. Metab Brain Dis., 32(6):1767-1783. (Impact factor: 2.297)
  18. Wu, YS, Chung I, Wong WF, Masamune A, Sim MS, and Looi CY (2016). Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Biochimica et Biophysica Act, 1861, 296-306. (Impact factor: 4.702)
  19. Maw Shin Sim, Ahmad Hatim, Shiau Hui Diong & Zahurin Mohamed (2014) Genetic Polymorphism in DTNBP1 Gene Is Associated With Methamphetamine-Induced Panic Disorder. J Addict Med 8(6): 431 437. (Impart factor: 2.129)
  20. Shiau Hui Diong, Nor Shuhadah Mohd Yusoff, Maw Shin Sim, Raja Elina Raja Aziddin, Zamri Chik, Rusdi Abdul Rashid, Norliza Chemi, Zahurin Mohamed (2014). Quantitation of methadone and its metabolite in patients under maintenance treatment. Journal of Analytical Toxicology (2014). (Tier 2; IF = 2.017) (ISI-Cited Publication)
  21. Sim MS, Hatim A, Reynolds GP, Mohamed Z. 2013. Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population. Pharmacogenomics 14(5):505-14.(Tier 1; Impact Factor = 3.97) (accepted for publication 17 Jan 2013) (ISI-Cited Publication)
  22. Sim, M. S., Hatim, A., Jaafar, N. F., Rajagopal, V. L., Mohamed, Z. (2011). Association of the FAAH, GSTP1 and SOD2 functional genetic polymorphisms with methamphetamine dependence in a Malaysian population. HUGO J. 5:193-194.
  23. Sim, MS; Sulaiman, AH; Jaafar, ANFA; Mohamed, Z. Association of SOD2 (superoxide dismutase 2) genetic polymorphisms with methamphetamine dependence in Malaysian population. Drug Metabolism Reviews 2011 May. 43:69-70
  24. M.S. SIM, A. HATIM, V.L. RAJ, M.H. HABIL AND Z. MOHAMED. 2010. Association of brain-derived neurotrophic factor (BDNF)Val66Met genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Research (2010) 357:91-96 Brain Research (Impact Factor = 2.463) (ISI-Cited Publication)
Article in Proceeding
  1. Tune, B.X.J., Sim, M.S. et al. (2022) MMP-9/MMP-2 Inhibitor Sensitises Human Oesophageal Squamous Cell Carcinoma towards Cisplatin and 5-Fluorouracil in Different Treatment Models. Journal of Angiotherapy 6(3) 705. https://doi.org/10.25163/angiotherapy.631C
  2. M.S.Sim, I.S.Parhar, T.Soga, P.Vijayapandi and Z.Mohamed. MicroRNA Expression Profiling of Methamphetamine Dependence in Rat Nucleus Accumbens Tissue. Public Health Genomics 2015;18(suppl 1):1-51
  3. M.S. Sim, A. Hatim, N.F. Jaafar, V.L. Raj1, Z. Mohamed. 2011. Association of the FAAH, SOD2 and GSTP1 functional genetic polymorphisms with methamphetamine dependence in a Malaysian population. Dubai, UAE. Human Genome meeting 2011, 4th Pan Arab Human genetics Conference, Genomics of Human Diversity & Heritable Disorder
  4. M.S. Sim, V.L. Raj, A.Hatim and Z.Mohamed. 2009. Association between single nucleotide polymorphisms of FAAH gene and GSTP1 gene with addiction to stimulants in the Malaysian population. Hong Kong. International Conference on Personalised Medicine and 5th Joint Conference on Pharmacogenetics. 19-20.
  5. M.S. SIM, V.L. RAJ, A.H.SULAIMAN AND Z.MOHAMED. 2008. Association Between FAH P129T Polymorphism and Addiction to Stimulants in the Malaysian Population. Istana Hotel, Kuala Lumpur. 33rd Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology. 134.

RESEARCH INTEREST

  • Pharmacogenomics (Pharmacogenomics)
  • Neurosciences (Neurosciences)
  • Human genetics (genetics)
  • Pharmacogenetics (Pharmacogenetics)
  • Pharmacoproteomics (Pharmacoproteomics)
  • Precision Medicine (Precision Medicine)

RESEARCH PROJECT

National
  1. 2019 - 2024, Long Term Research Grant Scheme (LRGS)
    Genome-wide Pharmacogenomics Study On Polydrug Abuse And Dependence And Therapeutic Response Of Methadone Maintenance Treatment At Selected Hot Spots In Malaysia ( Co-Researcher)
  2. 2020 - 2024, Fundamental Research Grant Scheme (FRGS)
    Elucidation Of The Effects Of Cigarette, Electronic Cigarette And Dual-use On Cellular Morphology, Biochemical And Genetic Profile Alterations Of Smokers ( Principal Investigator(PI))
  3. 2020 - 2024, Fundamental Research Grant Scheme (FRGS)
    Elucidation Of The Effects Of Cigarette, Electronic Cigarette And Dual-use On Cellular Morphology, Biochemical And Genetic Profile Alterations Of Smokers ( Principal Investigator(PI))
  4. 2020 - 2023, Government Agency
    Influence Of Dopaminergic System Gene Polymorphisms On Amphetamine- Type Stimulants (ats) Abuse And Dependence In The Multi-ethnic Malaysian Population ( Principal Investigator(PI))
  5. 2021 - 2022, RU Geran - ADEC
    Exploring The Use Of A Student Response System (srs) To Motivate And Instill A Safe Environment For Student Engagement During Online Classes ( Co-Researcher)
  6. 2018 - 2021, RU Geran - Fakulti Program
    Psychopharmacogenomics Study Of Drug Abuse And Dependance On Amphetamine-type Stimulants (ats) And Heroin In A Malaysian Population ( Principal Investigator(PI))
  7. 2019 - 2021, Bantuan Kecil Penyelidikan (BKP)
    Pharmacogenomics Study Of Drug Abuse And Dependence On Amphetamine-type Stimulants (ats) And Heroin In A Malaysian Population ( Principal Investigator(PI))
  8. 2020 - 2023, Long Term Research Grant Scheme (LRGS)
    Genome-wide Pharmacogenomics Study on Polydrug Abuse and Dependence, and therapeutic response of methadone maintenance treatment at Selected Hot Spots in Malaysia ( Consultant)
  9. 2020 - 2023, Fundamental Research Grant Scheme (FRGS)
    Elucidation of the effects of cigarette, electronic cigarette and dual-use on cellular morphology, biochemical and genetic profile alterations of smokers. ( Consultant)
  10. 2019 - 2022, Fundamental Research Grant Scheme (FRGS)
    Behavioral of Tetraspanin L6 Domain Family on Esophageal Squamous Cell Carcinoma Phenotypes and Chemoresistance: Investigation on MicroRNAs and Aptamer-Based Treatment ( Consultant)
  11. 2020 - 2022, YAYASAN PENYELIDIKAN OTAK, MINDA DAN NEUROSAINS MALAYSIA (YPOMNM)
    Influence of dopaminergic system gene polymorphisms on Amphetamine-Type Stimulants (ATS) abuse and dependence in the multi-ethnic Malaysian population ( Principal Investigator(PI))
  12. 2019 - 2021, UMS Grant
    The influence of interleukin-10 (IL-10) gene, interferon (IFN) gene & tumor necrosis factor (TNF) gene polymorphisms on susceptibility and protection against dengue Infection in Sabah ( Consultant)
  13. 2019 - 2020, MAHSA Grant
    Behavioral of Tetraspanin L6 Domain Family on Esophageal Squamous Cell Carcinoma Phenotypes and Chemoresistance: Investigation on MicroRNAs and Aptamer-Based Treatment ( Consultant)

CONSULTANCY PROJECT

  • Technical Consultant of The Company, CYTOMICS SDN. BHD
    01 Aug 2023 - 31 Jul 2025 (National)
  • Technical Consultant of The Company, CYTOMICS SDN. BHD., Consultant
    01 Apr 2022 - 31 Mar 2023 (University)
  • The Science Advisory Board for Advanx Health (Ubisana Innovations Sdn Bhd)., Advanx Health (Ubisana Innovations Sdn Bhd)
    01 Dec 2020 - 01 Dec 2022 (National)

PAPER PRESENTED

INVITED SPEAKER
  1. Pharmacogenomics of Drug Abuse and Dependence: From genetics to prevention and personalized medicine, SECOND INTERNATIONAL CONFERENCE ON 'NEW INSIGHTS OF PHARMACOECONOMICS PHARMACOEPIDEMIOLOGY, PHARMACOVIGILANCE', Chalapathi Institute of Pharmaceutical Sciences, India (International) (17 Sep 2019 - 18 Sep 2019)
  2. BDNF pharmacogenetics of methamphetamine abuse, 5th CINP Pasific-Asia Regional Meeting, Collegium Internationale Neuro-Psychopharmacologicum (CINP) (International) (19 Jun 2011 - 20 Jun 2011)
EVENT ORGANISER
  1. MicroRNA Expression Profiling of Methamphetamine Dependence in Rat Nucleus Accumbens Tissue, 2015 Golden Helix Symposia, The Golden Helix Foundation, London; University of Malaya, Kuala Lumpur (International) (11 Mar 2015 - 13 Mar 2015)
POSTER PRESENTER
  1. SOD2 Genetic Polymorphisms and Methamphetamine-Induced Psychosis and Dependence in the Malaysian Population, 2 ND INTERNATIONAL CONFERENCE ON PRECISION HEALTH IN INDUSTRIAL REVOLUTION (IR) 2023, UITM Puncak Alam (International) (26 Aug 2023 - 27 Aug 2023)
  2. MicroRNA Expression Profiling of Methamphetamine Dependence in Rat Nucleus Accumbens Tissue, 2015 Golden Helix Symposia , The Golden Helix Foundation, London; University of Malaya, Kuala Lumpur (International) (11 Mar 2015 - 13 Mar 2015)
  3. Association between single nucleotide polymorphisms of FAAH gene and GSTP1 gene with addiction to stimulants in the Malaysian population., International Conference on Personalised Medicine and 5th Joint Conference on Pharmacogenetics. Hong Kong., The Chinese University of Hong Kong  (International) (19 Sep 2009 - 20 Sep 2009)
  4. ASSOCIATION BETWEEN FAAH P129T POLYMORPHISM AND ADDICTION TO STIMULANTS IN THE MALAYSIAN POPULATION, 33rd Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology , The Malaysian Society for Biochemistry and Molecular Biology  (International) (27 Aug 2008 - 28 Aug 2008)
PRESENTER
  1. MicroRNA Expression Profiling of Methamphetamine Dependence in Rat Hippocampal Tissue, 3rd International Conference on Molecular Biology and Biotechnology (ICMBB2019), MSMBB (International) (24 Apr 2019 - 25 Apr 2019)
  2. Association of the FAAH, SOD2 and GSTP1 functional genetic polymorphisms with methamphetamine dependence in a Malaysian population., Human Genome meeting 2011, 4th Pan Arab Human genetics Conference, Genomics of Human Diversity & Heritable Disorder. Dubai., Human Genome Organization (HUGO) (International) (14 Mar 2011 - 17 Mar 2011)
KEYNOTE SPEAKER
  1. Pharmacogenomics of Drug Abuse and Dependence: From genetics to prevention and personalized medicine, MAHSA International Medical Technology Conference 2022 (Mi-MED-2022) with the theme of "SUSTAINABLE HEALTH IN THE POST PANDEMIC ERA", MAHSA University (International) (22 Jul 2022 - 23 Jul 2022)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2023) Final Year Project Proposal Presentation Assessor, University, (Internal Examiner)
  2. (2023) Appointed as a Panel Review for The Universiti Malaya Research Excellence Grant (Umreg) 2023, University, (Reviewer)
  3. (2023) Pelantikan Sebagai Panel Penilai Candidature Defence Untuk Semester 2, Sesi 2022/2023, University, (Internal Examiner)
  4. (2023) Appointed as a Panel Reviewer for The Umsc Ca.R.E Fund Research Grant (Umsc-Rg) & Dato' Mahmood Merican Medical Research Grant (Mmrg) 2023., University, (Reviewer)
  5. (2023) Appointed as An Assessor for Postgraduate Research Proposal, University, (Internal Examiner)
  6. (2023) Appointed as a Reviewer of a Research Article for Journal of Metabolic Brain Disease, International, (Reviewer)
  7. (2023) Appointment to Serve as Internal Examiner for Master Medical Science Viva-Voce Examination by Research, University, (Internal Examiner)
  8. (2022) Appointed as An Proposal Evaluator for a Phd Candidate, University, (Internal Evaluator)
  9. (2022) Appointment to Serve as Internal Examiner for Master Medical Science Examination by Research, University, (Internal Examiner)
  10. (2022) Appointment as Assessor for a Phd Candidature Defence, University, (Internal Evaluator)
  11. (2022) Appointment as An Interview Panel for The Intake of The Pharmacy Programme, University, (Internal Evaluator)
  12. (2022) Appointment as An Assessor for a Master Candidature Defence (Faculty of Medicine, UM), University, (Internal Assessor)
  13. (2022) Reviewed An Article Titled "Investigation of Mir-222 as a Potential Biomarker in Diagnosis of Patients With Methamphetamine Abuse Disorder", International, (Reviewer)
  14. (2021) Appointed as Evaluation Panel for The Faculty Research Grant (Gpf) Progress Report, University, (Internal Evaluator)
  15. (2021) Review An Article Titled 'Occurrence and Removal of Pharmaceuticals and Personal Care Products (Ppcps) from Drinking Water Sources', International, (Reviewer)
  16. (2021) Program Admission Interview Panel, University, (Internal Evaluator)
  17. (2020) Assessor of a Candidature Defence in Department of Pharmacology, Faculty of Medicine, UM. Title: Association of Single Nucleotide Polymorphisms and Physical Activity on Adiposity Parameters in Malaysian Adolescents. , (Internal Examiner)
  18. (2020) Assessor of a thesis submission seminar. Title: Clinical and genetic association of insulin resistance and multi-vessel stenosis in T2DM with coronary artery disease. Date: 27 February 2020. Time: 9.00 - 10 am, (Internal Examiner)
  19. (2020) Assessor of a Ph.D. Candidature Defence in Faculty of Pharmacy, UM. Title: Clinical and Genetic Markers Associated with Erythropoetin Deficiency Anemia in Pre-Dialysis Chronic Kidney Disease. , (Internal Examiner)
  20. (2020) Reviewed an article titled 'microRNA Let-7b-3p in Abuse of Methamphetamine'. Journal: Brazilian Journal of Pharmaceutical Sciences., (Reviewer)
  21. (2020) Reviewed a manuscript titled "Methamphetamine leads to the alterations of microRNA profiles in the nucleus accumbens of rats. " , (Reviewer)
  22. (2019) Reviewed an article titled: The Effects of Acute and Repeated Methylenedioxypyrovalerone (MDPV) Administration on Striatal Transcriptome Networks in Male Long Evans Rats. Neuroscience Letters. , (Reviewer)
  23. (2019) Assessor of a PhD Candidature Defense with the title "Clinical and Genetic Associations of Insulin Resistance and Severity of CAD in T2DM" , (Internal Examiner)
  24. (2019) Reviewed an article titled 'Comparison of Guilt and Shame between Man and Woman with Drug Addiction'. Invited by Journal of Forensic and Crime Studies (JFCS). , (Reviewer)
Contribution to external organisation
  1. (2024) Technical Advisor Cytomics Sdn. Bhd., National, (Technical Advisor)
  2. (2020) Appointed as The Science Advisory Board for Advanx Health (Ubisana Innovations Sdn Bhd)., Advanx Health (Ubisana Innovations Sdn Bhd), National
Contribution to event
  1. (2022) Head of The Logistic Team, International Symposium of Pharmacy Research (Impres 2022), International, (Event Organiser)
  2. (2022) High-Throughput Real-Time Pcr Workshop: Theory and Hands-On, National, (Event Organiser)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2022) Effect of SLC2A2 and SLC22A1 gene Polymorphisms on Glycemic Control and Metformin intolerance in Type 2 Diabetes Patients at St Paul's Hospital and Zewuditu Memorial Hospital, Addis Ababa, Ethiopia, Abraham Degaga Abdi (Addis Ababa University, Ethopia)
  2. (2021) Effect of SLC2A2 and SLC22A1 gene Polymorphisms on Glycemic Control and Metformin intolerance in Type 2 Diabetes Patients at St Paul's Hospital and Zewuditu Memorial Hospital, Addis Ababa, Ethiopia, Abraham Degaga Abdi (Addis Ababa University, Ethopia)
  3. (2020) CANCER PHARMACOLOGY AND THERAPEUTICS, Nur Syafiqah Rahim
  4. (2019) Association between Genetic Polymorphisms of HLA and Non-HLA Genes with Dengue Fever Infection in Sabah Population., RHANYE MAC GUAD
  5. (2018) Sexual dysfunction in Methadone treatment patients, Shahrzard Riahi
  6. (2016) Study of the Use of Bupropion in Sexual Dysfunction Following Methodone Maintenance Therapy for Heroin Addiction in Male Patients., SHAHRZAD RIAHI
Master
  1. (2019) PSYCHOPHARMACOGENOMICS STUDY OF DRUG ABUSE AND DEPENDENCE ON AMPHETAMINE-TYPE STIMULANTS (ATS) IN A MALAYSIAN MALE POPULATION, HASIF ADLI ZAKARIAH
Under Graduate Students
  1. (2022) PENYALAHGUNAAN DAN KETAGIHAN BAHAN TERLARANG DALAM KALANGAN REMAJA DI MALAYSIA
  2. (2021) Final Year Project
  3. (2019) Final Year Project
  4. (2018) Final year project

TEACHING

Bachelor
  1. (2022) OIA2009 - Basic Immunology and Pharmacotherapy of Immune Disorders
  2. (2022) OIA3021 - Pharmaceutical Biotechnology
  3. (2022) OIA1009 - Pharmacotherapy for Eent and Haematological Disorders
  4. (2022) OIA3012 - Pharmacotherapy for Psychiatric Disorders
  5. (2022) OIA4010 - Pharmacotherapy for Special Populations
  6. (2022) OIA4006 - Research Methodology
  7. (2022) MIX3002 - Smoking Cessation Program
  8. (2022) GDO0013 - Tobacco and Smoking Cessation Programme
  9. (2021) OIA3006 - Anaesthesia and Pharmacotherapy for Neurological Disorders
  10. (2021) OIA2009 - Basic Immunology and Pharmacotherapy of Immune Disorders
  11. (2021) OIA1009 - Pharmacotherapy for Eent and Haematological Disorders
  12. (2021) MWEF4109 - Research Project
  13. (2021) MIX3002 - Smoking Cessation Program
  14. (2021) GDO0013 - Tobacco and Smoking Cessation Programme
  15. (2019) MIB3006 - Anaesthesia and Pharmacotherapy for Neurological Disorders
  16. (2019) MIB4010 - Pharmacotherapy for Special Populations
  17. (2018) MIB3012 - Pharmacotherapy for Psychiatric Disorders

SOCIAL RESPONSIBILITY ACTIVITIES

  • Corporate Social Responsibility Program Entitled How Does Your Body Process Medicine With Sri Aria Elementary School On 15th, 28th & 30th June 2021, (15 Jun 2021 - 30 Jun 2021) (University)

COURSE ATTENDED

Internal / External Course
INTERNAL COURSE- ORGANIZED BY PTJ
  1. WORKSHOP: EMERALD TEACHING & LEARNING, Universiti Malaya (05 Feb 2018 - 09 Feb 2018)
  2. WORKSHOP ON DESIGNING AND DEVELOPING ASSESSMENT METHODS AND QUESTIONS, Putrajaya Marriott Hotel (13 Oct 2022 - 13 Oct 2022)
EXTERNAL COURSE
  1. SELF LEADERSHIP: ESSENTIAL SKILLS TO HELP YOU REALIZE YOUR POTENTIAL, UM (24 Jun 2019 - 24 Jun 2019)
  2. OUTCOME-BASED LEARNING WORKSHOP, Faculty of Pharmacy, UM (04 Nov 2019 - 05 Nov 2019)
  3. KURSUS PEMBANGUNAN KELESTARIAN KAMPUS UM, Asia-Europe Institute, University of Malaya (11 Dec 2019 - 11 Dec 2019)
COURSES ORGANIZED BY PTJ
  1. EMERALD RESEARCH SUPERVISION, University of Malaya (27 Aug 2018 - 28 Aug 2018)
INTERNAL COURSE
  1. KURSUS ONLINE GOOGLE HANGOUTS MEETS, ZOOM & MICROSOFT TEAMS, Rumah/Pejabat (10 Apr 2020 - 10 Apr 2020)
  2. PROGRAM TRANSFORMASI MINDA, Secara Dalam Talian (22 Feb 2021 - 25 Feb 2021)
External Course
NATIONAL
  1. Educator@Virtual Learning Environment Program, Online (26 Aug 2021 - 15 Sep 2021)
  2. Webinar: Cyanobacterial Natural Products and Their Biosynthetic Genes, Zoom (06 Sep 2021 - 06 Sep 2021)